Dermal Filler - Medical Devices Pipeline Assessment, 2019

Published : Feb-2019

No. of Pages : 101

order by fax Inquire before Buying request discount

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Dermal Filler Overview
3 Products under Development
3.1 Dermal Filler - Pipeline Products by Stage of Development
3.2 Dermal Filler - Pipeline Products by Territory
3.3 Dermal Filler - Pipeline Products by Regulatory Path
3.4 Dermal Filler - Pipeline Products by Estimated Approval Date
3.5 Dermal Filler - Ongoing Clinical Trials
4 Dermal Filler - Pipeline Products under Development by Companies
4.1 Dermal Filler Companies - Pipeline Products by Stage of Development
4.2 Dermal Filler - Pipeline Products by Stage of Development
5 Dermal Filler Companies and Product Overview
5.1 Aeon Astron Corporation Company Overview
5.2 Allergan Plc Company Overview
5.3 Almirall Ltd Company Overview
5.4 Bioxis Pharmaceuticals Company Overview
5.5 BMG Pharma srl Company Overview
5.6 Bmi Korea Co Ltd Company Overview
5.7 Celltrix AB Company Overview
5.8 CollPlant Holdings Ltd Company Overview
5.9 EternoGen Aesthetics LLC Company Overview
5.10 Genzyme Corp Company Overview
5.11 Innovia LLC Company Overview
5.12 Juvenis Ltd Company Overview
5.13 Khorionyx SA Company Overview
5.14 Medy-Tox Inc Company Overview
5.15 Mesoestetic Pharma Group SL Company Overview
5.16 Moma Therapeutics, Inc. Company Overview
5.17 N8 Medical Inc Company Overview
5.18 Oligo Medic Inc Company Overview
5.19 PB&B SA Company Overview
5.20 PetVivo Holdings Inc Company Overview
5.21 Regenscientific Company Overview
5.22 Samyang Biopharmaceuticals Corp Company Overview
5.23 Sebana Medical Ltd Company Overview
5.24 Sekisui Medical Co Ltd Company Overview
5.25 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.26 Shin Poong PharmCo Ltd Company Overview
5.27 Sinclair Pharma PLC Company Overview
5.28 Sofregen Medical Inc Company Overview
5.29 TEI Biosciences Inc Company Overview
5.30 University of California Santa Barbara Company Overview
6 Dermal Filler- Recent Developments
6.1 Jul 19, 2018: Suneva Medical promotes Patricia Altavilla to chief operating officer
6.2 Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30 June 2018
6.3 Jun 04, 2018: SWAG Penis Enhancement Procedure Developed by Top Plastic Surgeon Achieving Optimal Results
6.4 May 21, 2018: Nestle Skin Health Announces the FDA Approval of Restylane Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
6.5 May 15, 2018: BTG: Final Results For year ended 31 March 2018
6.6 May 09, 2018: FibroGen Reports First Quarter 2018 Financial Results
6.7 May 08, 2018: Smith & Nephew: Change of Directorate
6.8 May 08, 2018: CollPlant Files U.S. Patent Application for Next Generation Dermal Filler
6.9 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report
6.10 May 02, 2018: Anika Reports First Quarter 2018 Financial Results
6.11 Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017
6.12 Apr 30, 2018: Sinclair secures 23 million debt facility
6.13 Apr 09, 2018: Merz Aesthetics Launches New Belotero Lips Dermal Filler Products
6.14 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew
6.15 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth
6.16 Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And Director
6.17 Mar 01, 2018: Smith & Nephew: Change in Directorate
6.18 Feb 27, 2018: FibroGen Announces Fourth Quarter and Full Year 2017 Financial Results
6.19 Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results
6.20 Feb 16, 2018: Merz North America to Highlight Treatments at American Academy of Dermatology Annual Meeting
6.21 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year 2017 Results
6.22 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As Non-Executive Director
6.23 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive Director
6.24 Jan 16, 2018: Galderma Introduces Restylane Skinboosters
6.25 Jan 16, 2018: Sinclair Pharma: Ellanse Approved for Brazil
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Dermal Filler - Pipeline Products by Stage of Development
Table 2: Dermal Filler - Pipeline Products by Territory
Table 3: Dermal Filler - Pipeline Products by Regulatory Path
Table 4: Dermal Filler - Pipeline Products by Estimated Approval Date
Table 5: Dermal Filler - Ongoing Clinical Trials
Table 6: Dermal Filler Companies - Pipeline Products by Stage of Development
Table 7: Dermal Filler - Pipeline Products by Stage of Development
Table 8: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 9: BioDermal Filler - Product Status
Table 10: BioDermal Filler - Product Description
Table 11: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: HA Threads - Product Status
Table 13: HA Threads - Product Description
Table 14: JUVEDERM Volbella - Tear Trough - Product Status
Table 15: JUVEDERM Volbella - Tear Trough - Product Description
Table 16: Juvederm Vollure XC - Product Status
Table 17: Juvederm Vollure XC - Product Description
Table 18: JUVEDERM VOLUMA - Nose - Product Status
Table 19: JUVEDERM VOLUMA - Nose - Product Description
Table 20: JUVEDERM Voluma Global - Malar Augmentation - Product Status
Table 21: JUVEDERM Voluma Global - Malar Augmentation - Product Description
Table 22: VYC-25L Hyaluronic Acid Injectable Gel - Product Status
Table 23: VYC-25L Hyaluronic Acid Injectable Gel - Product Description
Table 24: Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Hyaluronic Acid Facial Filler - Product Status
Table 26: Hyaluronic Acid Facial Filler - Product Description
Table 27: Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
Table 28: CYTOSIAL Deep Wrinkle - Product Status
Table 29: CYTOSIAL Deep Wrinkle - Product Description
Table 30: CYTOSIAL Medium - Product Status
Table 31: CYTOSIAL Medium - Product Description
Table 32: Cytosial Volume - Product Status
Table 33: Cytosial Volume - Product Description
Table 34: Cytosmile - Product Status
Table 35: Cytosmile - Product Description
Table 36: MTI-12 - Surgical Repair - Product Status
Table 37: MTI-12 - Surgical Repair - Product Description
Table 38: BMG Pharma srl Pipeline Products & Ongoing Clinical Trials Overview
Table 39: SGA300 - Product Status
Table 40: SGA300 - Product Description
Table 41: SGA302 - Product Status
Table 42: SGA302 - Product Description
Table 43: Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 44: BMI4002 - Product Status
Table 45: BMI4002 - Product Description
Table 46: Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Credurance - Product Status
Table 48: Credurance - Product Description
Table 49: CollPlant Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Next Generation Dermal Filler - Product Status
Table 51: Next Generation Dermal Filler - Product Description
Table 52: EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Cellifique - Product Status
Table 54: Cellifique - Product Description
Table 55: Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 56: PREVELLE Lift - Product Status
Table 57: PREVELLE Lift - Product Description
Table 58: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Wrinkle Filler - Product Status
Table 60: Wrinkle Filler - Product Description
Table 61: Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Tenergel - Product Status
Table 63: Tenergel - Product Description
Table 64: Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Autologous Globin Dermal Filler - Product Status
Table 66: Autologous Globin Dermal Filler - Product Description
Table 67: Medy-Tox Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 68: MT943 - Product Status
Table 69: MT943 - Product Description
Table 70: Neuramis Deep Lidocaine - Product Status
Table 71: Neuramis Deep Lidocaine - Product Description
Table 72: Neuramis Volume Lidocaine - Product Status
Table 73: Neuramis Volume Lidocaine - Product Description
Table 74: Medy-Tox Inc - Ongoing Clinical Trials Overview
Table 75: Neuramis Volume Lidocaine - Clinical Study of Neuramis Volume Lidocaine to Evaluate the Efficacy and Safety for Temporary Restoring the Mid-face Volume
Table 76: Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview
Table 77: mRDX-02-17 - Product Status
Table 78: mRDX-02-17 - Product Description
Table 79: Mesoestetic Pharma Group SL - Ongoing Clinical Trials Overview
Table 80: mRDX-02-17 - A Multicentre, Open-label, Interventional, Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation

1.2 List of Figures
Figure 1: Dermal Filler - Pipeline Products by Stage of Development
Figure 2: Dermal Filler - Pipeline Products by Territory
Figure 3: Dermal Filler - Pipeline Products by Regulatory Path
Figure 4: Dermal Filler - Pipeline Products by Estimated Approval Date
Figure 5: Dermal Filler - Ongoing Clinical Trials

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Dermal Filler - Medical Devices Pipeline Assessment, 2019

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027